We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
TECENTRIQ atezolizumab (rch) 840 mg/14 mL injection concentrated vial (310681)
ARTG ID 310681
ARTG Name
TECENTRIQ atezolizumab (rch) 840 mg/14 mL injection concentrated vial
Product name
TECENTRIQ atezolizumab (rch) 840 mg/14 mL injection concentrated vial
ARTG Date
Registration Type
Medicine
Therapeutic good type
Medicines
Sponsor
Ingredients
atezolizumab
Licence category
RE
Licence status
A
Summary
Product Information
Consumer Medicine Information